MGC invests in wHITE SPACE eNTERPRISEs AND tWO OTHER companies to accelerate medical business development
Precise forming technology is required to reduce the size and increase the functionality of test/diagnosis devices used for rapid diagnosis. Expecting to fully leverage its chemical and material expertise in this field, MGC is investing in CONSONAL BIOTECHNOLOGIES Co., Ltd., Japan's largest comprehensive research institution “RIKEN” certified venture, and WhiteSpace Enterprises Corporation, a venture created from innovation at the University of Arizona to conduct research and development of biomolecular technologies with a view to entering the market in the future.
Vertical Flow Assay Being Developed to Detect Biological Threats at the Point of Need
NEW YORK (360Dx) – Researchers at the University of Arizona and University of Nevada are working to develop a vertical flow immunoassay for the detection of pathogens that pose a threat to national security and public health.
According to Frederic Zenhausern, one of the study authors and a director of the Center for Applied NanoBioscience & Medicine at the U of Arizona, Phoenix, the DoD was interested in the development of a multiplexed panel that simultaneously detects several biothreat agents.
September 2016 – Battelle Memorial Institute enters contractual agreement with Whitespace Enterprises for assessing its rapid DNA technology.
WSE donated funds to support global health interest group
"We are excited to announce that we have reached 84% of our initial goal in just a few weeks. Thank you so much to all of our donors and everyone who has supported this project - we appreciate you so much. We also want to extend a special thank you to two companies that have supported us with large amount donations: Retail Me Not and WhiteSpace Enterprises."